News Headlines Article

Merck’s 2Q net income drops 52% on higher costs, charges
USA Today

Drugmaker Merck on Friday reported a 52% drop in second-quarter net income, due to big merger and restructuring charges and lower income from partnerships. Merck (MRK), the world’s second-biggest drug company by revenue, says its net income amounted to $752.4 million, or 24 cents a share. That’s down from $1.56 billion, or 74 cents a share, in 2009’s second quarter.